Cash Flow Woes Delay THC BioMed’s Financials, Triggers Trade Order

THC BioMed's CEO and CFO offered bridge financing to partly cover the fees.

Vancouver-based cannabis producer THC BioMed Intl Ltd. (OTC: THCBF) is facing delays in filing its annual financial statements due to unpaid auditor fees, which also led to a management cease trade order by the British Columbia Securities Commission.

The company did not submit its financial statements for the fiscal year ending July 31, 2023, by the prescribed deadline of Nov. 28, 2023. The company said in a news release that the delay stems from cash flow issues that prevented the firm from paying its auditor.

In response, THC BioMed’s CEO and CFO offered bridge financing to partly cover these fees, and the company is exploring additional bridge financing options to fulfill the remaining financial obligations.

The company expects to receive payments from various provincial cannabis operations in Canada later this month, which it believes will be enough to settle the outstanding audit fees.

For now, management is prohibited from trading company securities until the financials are filed. The firm is looking to submit its overdue annual report by the end of the month, as well as its interim statements for the period ending Oct. 30, 2023, by Feb. 5.

The company is obligated to provide biweekly default status reports until its annual filings are completed. The order doesn’t restrict the trading of the company’s shares by the general public.

THC BioMed also confirmed that there have been no significant business developments since the filing of its last interim financial reports for the period ending April 30, 2023.

“The company continues to make best efforts to correct the deficiency by increasing the company’s cash flow,” the firm said. “The company is in the process of shipping its newly released products which it expects will increase its cash flow in order for the company to satisfy the auditor’s requirements to complete the annual filings.”

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at adam.jackson@crain.com.


One comment

  • Captain truthalicious

    February 8, 2024 at 1:39 pm

    Thc biomed is a scam company that raped all its investors

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.